|
|  |
Home
> Research > The Amy Strelzer Manasevit Research Program
Amy Strelzer Manasevit was a vibrant young mother who was diagnosed with multiple myeloma in 1993. A marrow transplant was her only hope for a cure. Following a long and complicated search for a matched, unrelated donor, Amy received her transplant. Even though it was a success, the process severely depleted her immune system and she died of pneumonia six weeks after returning home to her family.
In 1997, Amy's family and friends collaborated with The Marrow Foundation and the National Marrow Donor Program (NMDP) to establish this research program as a tribute to Amy.
Since 1998, The Marrow Foundation and the National Marrow Donor Program (NMDP) have awarded more than $4 million to fund research aimed at finding solutions to post-transplant complications, such as infections, graft-versus-host disease (GVHD) and disease relapse. The research done today may help more transplant patients live longer and healthier lives tomorrow.
To stimulate new initiatives, The Marrow Foundation has attracted generous contributions to the research program from individuals as well as many corporations and foundations, including The Judith and Jean Adams Charitable Foundation, Baxter Healthcare, the Jacob and Hilda Blaustein Foundation of Baltimore, Boehringer-Ingelheim Pharmaceuticals, Inc., Fujisawa, the General Motors Cancer Research Foundation, the F.M. Kirby Foundation Inc. and SuperGen.
|
|
See Also:
Helping Patients Overcome Financial Barriers
|